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 Synthetic Discussion.  
The preparation of the oligonucleotides containing UA was accomplished via the the appropriate 
phosphoramidite. The synthesis of this was performed as shown in Scheme S1. The synthesis 
started from the known ribose-derivative methyl 3,5-bis-O-(p-chlorobenzyl)-2-deoxy-2-
hydroxymethyl-ɑ-D-ribofuranose 1.S1 Adenine was introduced as the first nucleobase using a two 
step procedure involving the activation of the primary hydroxy group of 1 to the triflate, which was 
subsequently replaced by adenine to generate nucleoside 2. The presence of 
3
JCH coupling between 
the 2'-methylene protons and C-4 as well as C-8 from the adenine in the HMBC NMR spectrum of 
2 confirmed the N
9
-alkylation. Standard protection of the exocylic amino group afforded a fully 
protected nucleoside 3. Vorbrüggen coupling of 3 with silylated uracil was then accomplished in the 
presence of tin(IV) chloride as the Lewis acid to obtain double-headed nucleoside 4. Presence of 
coupling between H-1' and C2 as well as C-6 of the uracil in the HMBC NMR spectrum of 4 
confirmed the formation of the double headed nucleoside.  The chlorobenzyl groups were removed 
in a hydrogenation reaction to obtain free double-headed nucleoside 5. The ROESY spectrum of 5 
confirmed the β-configuration as ROE contacts were observed between H6 (uracil) and H2', and 
between H1' and H4', and between H1' and the methylene protons. Subsequent DMT-protection 
afforded 6 and  phosphitylation provided the phosphoramidite 7. 
 
 
 
 
                                                 
S1
 N.-S. Li and J. A. Piccirilli, J. Org. Chem. 2004, 69, 4751. 
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Scheme S1. Reagents and conditions: (a) i. Tf2O, pyridine, DCM, ii. Adenine, NaH, DMF, 51%. (b)  
i. BzCl, pyridine, ii. NH3 in methanol, 85%. (c) HMDS, (NH4)2SO4, CH3CN, TMSOTf, 58% (d) 
Pd(OH)2/C, MeOH 41% (e) DMTr Cl, pyridine 48% (f) NC(CH2)2OPClN(iPr)2, EtN(iPr)2, CH2Cl2 
(ClCH2)2, 65%. 
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Experimental data for the synthetic preparations  
 
General. All commercial reagents were used as supplied, except CH2Cl2 which was distilled prior 
to use. Anhydrous solvents were dried over 4 Å activated molecular sieves (CH2Cl2, DMF, pyridine 
and, DCE) or 3 Å activated molecular sieves (CH3CN). All reactions were carried out under an 
atmosphere of argon or nitrogen, when using anhydrous solvents. Reactions were monitored using 
TLC analysis with Merck silica gel plates (60 F254). To visualize the plates, they were exposed to 
UV light (254 nm) and/or immersed in a solution of 5% H2SO4 in methanol followed by charring. 
Standard column chromatography was performed using silica gel 60 (0.040 – 0.063 mm). 1H NMR, 
13
C NMR and 
31
P NMR spectra were recorded at 400 MHz, 101 MHz and 162 MHz respectively. 
Chemical shift values (δ) are reported in ppm relative to either tetramethylsilane (1H NMR) or the 
deuterated solvents as internal standard for 
13
C NMR (δ CDCl3 77.160 ppm, DMSO-d6 39.52 ppm), 
and relative to 85% H3PO4 as external standard for 
31
P NMR. 2D spectra (
1
H-
1
H COSY, and 
1
H-
13
C 
HSQC) have been used in assigning 
1
H and 
13
C NMR signals. High resolution ESI (quadrupole) 
mass spectra were recorded in positive mode. 
 
Synthesis of 2-C-(adenine-9-yl)methyl-3,5-bis-O-(4-chlorobenzyl)-2-deoxy-ɑ-D-ribofuranose 
(2). To a stirred solution of the ribose derivative 1 (2.0 g, 4.68 mmol) in anhydrous CH2Cl2 (50 mL) 
at –70 °C was added dried pyridine (0.5 mL, 6.2 mmol)) and trifluoromethanesulfonic anhydride 
(1.0 mL, 5.94 mmol). The reaction mixture was allowed to warm to –20°C and stirred for 1 h. The 
mixture was diluted with CH2Cl2 (30 mL) and added H2O (20 mL) and a saturated aqueous solution 
of NaHCO3 (10 mL). The phases were separated and the aqeous phase was extracted with CH2Cl2 
(20 mL). The combined organic phase was dried (Na2SO4) and concentrated under reduced 
pressure. The residue was used without purification in the next step. To a stirred suspension of 
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adenine (6.3 g, 46.8 mmol) in anhydrous DMF (50 mL) was added NaH (a 60% dispension in oil, 
1.31 g, 32.7 mmol). The mixture was stirred at 70 °C for 10 min. and then at rt. A solution of the 
crude triflate derivative and a catalytic amount of 18-crown-6 (200 mg) in DMF (20 mL) was 
added. The reaction mixture was stirred at 50°C for 2h and  at room temperature  for 16 h and then 
concentrated under reduced pressure. The residue was dissolved in EtOAc (100 mL) and the 
solution was washed with a saturated aqueous solution of NaHCO3 (50 mL) and brine (50 mL), and 
the combined aqueous phase was extracted with EtOAc (2 × 50 mL). The combined organic phase 
was dried (Na2SO4) and concentrated under reduced pressure. The residue was purified by column 
chromatography (0 – 5%  MeOH in CH2Cl2) to afford the product 2 (1.3 mg, 51%) as a white foam. 
Rf 0.4 (6% MeOH in CH2Cl2); 
1
H NMR (400 MHz, CDCl3) δ 8.34 (s, 1H, H2), 7.73 (s, 1H, H8), 
7.31-7.25 (m, 4H, Ar), 7.19 (m, 4H, Ar), 6.14 (s, 2H, NH2), 4.75 (d, J = 4.9 Hz, 1H, H1'), 4.56 (d, J 
= 12.3 Hz, 1H, ArCH2), 4.47-4.41 (m, 4H, 2'-CH2, ArCH2), 4.38 (d, J = 12.3 Hz, 1H, ArCH2), 4.33 
(m, 1H, H4'), 3.91 (dd, J = 7.3, 1.8 Hz, 1H, H3'), 3.43 (s, 3H, OCH3), 3.40 (m, 1H, H5'), 3.32 (dd, J 
= 9.9, 5.9 Hz, 1H, H5'), 3.03 (m, 1H, H2'); 
13
C NMR (101 MHz, CDCl3) δ 155.7 (C6), 152.9 (C2), 
150.1 (C4), 141.5 (C8), 136.2, 136.2, 133.8, 133.7, 129.3, 129.1, 128.7, 128.7 (Ar), 119.8 (C5), 
104.5 (C1'), 83.5 (C4´), 79.1 (C3'), 72.8 (ArCH2), 71.3 (ArCH2), 70.5 (C5'), 55.4 (OCH3), 46.3 (2'-
CH2), 39.4 (C2'); ESI HRMS: m/z 566.1331 ([M + Na]
+
, C26H27Cl2N5O4Na
+
 calcd 566.1333). 
 
 Synthesis of 2-C-(N6-benzoyladenine-9-yl)methyl-3,5-bis-O-(4-chlorobenzyl)-2-deoxy-ɑ-D-
ribofuranose (3). Compound 2 (1.25 mg, 2.29 mmol) was coeporated with anhydrous pyridine (20 
mL) and redissolved in the same solvent (20 mL). The solution was stirred at 0°C and added 
benzoyl chloride (662 L, 5.72 mmol). The reaction mixture was stirred at room temperature  for 16 
h and then concentrated under reduced pressure. The residue was coevaporated with toluene (2 × 30 
mL) was and then dissolved in MeOH (60 mL) saturated with ammonia. The solution was stirred at 
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0°C for 30 min. and then concentrated under reduced pressure. The residue was dissolved in EtOAc 
(60 mL) and the solution was washed with water (2 × 50 mL) and the combined aqueous phase was 
extracted with EtOAc (2 ×20 mL). The combined organic phase was dried (Na2SO4) and 
concentrated under reduced pressure. The residue was purified by flash column chromatography (0 
– 3%  MeOH in CH2Cl2) to afford the product 3 (1.26 g, 85%) as a white foam.  Rf 0.4 (4% MeOH 
in CH2Cl2); 
1
H NMR (400 MHz, CDCl3) δ 8.92 (s, 1H, NH), 8.79 (s, 1H, H2), 8.03 (d, J = 7.3 Hz, 
2H, Ar), 7.94 (s, 1H, H8), 7.62 (m, 1H, Ar), 7.55-7.52 (m, 2H, Ar), 7.32-7.30 (m, 4H, Ar), 7.23-
7.19 (m, 4H, Ar), 4.77 (d, J = 5.0 Hz, 1H, H1'), 4.57-4.39 (m, 6H, ArCH2, 2'-CH2), 4.34 (m, 1H, 
H4'), 3.93 (dd, J = 7.4, 2.2 Hz, 1H, H3'), 3.45 – 3.42 (m, 4H, OCH3, H5'), 3.35 (dd, J = 10.0, 5.8 
Hz, 1H, H5'), 3.05 (m, 1H, H2'); 
13
C NMR (101 MHz, CDCl3) δ 164.6 (C=O), 152.5, 152.2 (C6, 
C2), 149.4, 144.0 (Ar, C8), 136.2, 136.0, 133.8, 133.7, 132.8, 132.1, 129.2, 129.0, 128.9, 128.7, 
128.6, 128.4, 127.9, 123.2 (Ar, C4, C5), 104.3 (C1'), 83.4 (C4'), 79.0 (C3'), 72.8 (ArCH2), 71.3 
(ArCH2), 70.5 (C5'), 55.3 (OCH3), 46.2 (C2´), 39.5 (2'-CH2); ESI HRMS: m/z 648.1776 ([M + H]
+
, 
C33H32Cl2N5O5
+
 calcd 648.1775).  
 
 Synthesis of 2'-C-(N6-benzoyladenine-9-yl)methyl-3',5'-bis-O-(4-chlorobenzyl)-2'-deoxy-
uridine (4). A mixture of isonucleoside 3 (0.32 g, 0.5 mmol) and uracil (200 mg, 1.78 mmol) was 
coevaporated with anhydrous CH3CN  (2 × 10 mL) and then suspended in the same solvent (10 
mL). To the stirred suspension was added (NH4)2SO4 (8 mg) and HMDS (1.0 mL). The reaction 
mixture was stirred at 75ºC for 1 h to obtain a clear solution and was then stirred to room 
temperature and added SnCl4 (25 L, 0.212 mmol) under argon. The reaction mixture  was stirred at 
room temperature for 16 h and then carefully quenched by the addition of a saturated aqueous 
solution of NaHCO3 (30 mL). The mixture was filtered through celite and the filter was washed 
with CH2Cl2 (50 mL). The layers were separated and the aqueous phase was extracted with CH2Cl2 
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(20 mL). The combined organic phase was dried (NaSO4) and concentrated under reduced pressure. 
The residue was purifed by column chromatography (0 – 3%  MeOH in CH2Cl2) to give the pure -
nucleoside 4 (210 mg, 58%) as a white foam; 
1
H NMR (400 MHz, CDCl3) δ 11.50 (br s, 1H, NH), 
10.07 (s, 1H, NH), 8.71 (s, 1H, H2(A)), 8.09 (s, 1H, H8(A)), 7.91 (d, J = 7.6 Hz, 2H, Ar), 7.45 (m, 
1H, Ar), 7.37-7.33 (m, 6H, Ar), 7.28-7.21 (m, 5H, Ar, H6(U)), 6.35 (d, J = 9.0 Hz, 1H, H1´), 5.10 
(d, J = 8.0 Hz, 1H, H5(U)), 4.61-4.47 (m, 5H, 2'-CH2, ArCH2), 4.41 (d, J = 11.8 Hz, 1H, ArCH2), 
4.30 (s, 1H, H4'), 4.16 (d, J = 5.3 Hz, 1H, H3'), 3.68 (dd, J = 10.2, 3.0 Hz, 1H, H5'), 3.57-3.39 (m, 
2H, H5', H2'); 
13
C NMR (101 MHz, CDCl3) δ 166.2, 162.8, 152.6, 151.7, 150.6, 150.2, 143.8, 
138.7, 135.5, 135.2, 134.3, 134.2, 133.9, 132.4, 129.2, 129.1, 129.0, 128.9, 128.6, 128.2, 122.5 
(C=O, Ar, C2,4,5,6,8(A), C2,4,6(U)), 102.8 (C5(U)), 86.9 (C1'), 81.9 (C4'), 80.4 (C3'), 73.1 
(ArCH2), 71.0 ((C5'), 70.8 (ArCH2), 45.5 (C2'), 41.2 (2'-CH2); ESI HRMS: m/z 750.1573 ([M + 
Na]
+
, C36H31Cl2N7O6Na
+
 calcd 750.1606). 
 
 Synthesis of 2'-C-(N6-benzoyladenine-9-yl)methyl-2'-deoxyuridine (5). To a stirred solution of 
compound 4 (440 mg, 0.45 mmol) in MeOH (15 mL) was added Pd(OH)2/C (10-20 wt%, 230 mg), 
and the suspension was degassed with Argon for 30 min. and then with hydrogen for 1 hour. The 
mixture was stirred at rt under a hydrogen atmosphere for 35 h. The suspension was filtrated 
through a layer of celite, which was subsequently washed with warm MeOH (30 mL). The 
combined filtrates were concentrated under reduced pressure, and the residue was purified by 
column chromatography (0-12% MeOH) to give the product 5 as a white solid powder (120 mg, 
41%) containing ~10% of a compound with a hydrogenated uracil. Rf 0.3 (12% MeOH in CH2Cl2). 
1
H NMR (400 MHz, MeOH-d4+CDCl3)  8.61 (s, 1H, H2(A)), 8.23 (s, 1H, H8(A)), 7.99 (d, J = 8.0 
Hz, 2H, Ar), 7.82 (d, J = 8.0 Hz, 1H, H6(U)), 7.55 (m, 1H, Ar), 7.48-7.44 (m, 2H, Ar), 6.18 (d, J = 
9.0 Hz, 1H, H1'), 5.53 (d, J = 8.0 Hz, 1H, H5(U)), 4.60 (m, 1H, 2´-CH2), 4.44 (dd, J = 14.4 Hz, 6.4 
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Hz, 1H, 2´- CH2), 4.16 (d, J = 5.2 Hz, 1H, H3'), 4.02 (s, 1H, H4'), 3.69 (dd, J = 12.0 Hz, 2.8 Hz, 
H5'), 3.61 (dd, J = 12.0 Hz, 2.8 Hz, H5'), 3.00 (m, 1H, H-2'); 
13
C NMR (101 MHz, MeOH-
d4+CDCl3)   167.9, 165.8, 153.3, 152.4, 151.2, 146.0, 142.0, 134.9, 134.0, 129.9, 129.5, 124.4 (Ar, 
C2,4,5,6,8(A), C2,4,6(U)), 103.6 (C5(U)), 89.1 (C4'), 88.0 (C1'), 73.3 (C3'), 63.3 (C5'), 50.2 (C2'), 
41.3 (2´-CH2);  ESI HRMS: m/z 480.1631 ([M - H]
+
, C22H21N7O6.H
+
 calcd. 480.1626). 
 
Synthesis of 5'-O-(4,4'-dimethoxytrityl)-2'-C-(N6-benzoyladenine-9-yl)methyl-2'-deoxyuridine 
(6). The double-headed nucleoside 5 (105 mg, 0.21 mmol) was co-evaporated with anhydrous 
pyridine (2  5 mL) and redissolved in the same solvent (5 mL). 4,4'-Dimethoxytrityl chloride (90 
mg, 0.26 mmol) was added and the reaction mixture was stirred at room temperature for 16 h. The 
reaction was quenched by the addition of 2-3 drops of absolute ethanol and the mixture was 
concentrated under reduced pressure. The residue was dissolved in CH2Cl2 (20 mL) and the mixture 
was washed with a saturated aqueous solution of NaHCO3 (2×10 mL). The combined aqueous 
phase was extracted with CH2Cl2 (2  10 mL), and the combined organic phase was dried (Na2SO4) 
and concentrated under reduced pressure. The residue was purified by column chromatography (0-
6% MeOH in CH2Cl2) to give the product 6 as a pale yellow solid (82 mg, 48%). Rf 0.4 (6% MeOH 
in CH2Cl2). 
1
H NMR (400 MHz, CDCl3)  10.24 (bs, 1H, NH), 9.46 (bs, 1H, NH), 8.78 (s, 1H, 
H2(A)), 8.27 (s, 1H, H8(A)), 8.01 (d, J = 7.6 Hz, 2H, Ar), 7.63 (d, J = 8.0 Hz, 1H, H6(U)), 7.57 (t, 
J = 7.6 Hz, 1H, Ar), 7.48 (t, J = 7.6 Hz, 2H, Ar), 7.24-7.11 (m, 9H, Ar), 6.76-6.73 (m, 4H, Ar), 6.21 
(d, J = 9.0 Hz, 1H, H1'), 5.89 (br s, 1H, 3'-OH), 5.37 (d, J = 8.0 Hz, 1H, H5(U)), 4.66 (m, 1H, 2'-
CH2), 4.49 (m, 1H, 2'-CH2), 4.24 (m, 1H, H4'), 4.00 (m, 1H, H3'), 3.73 (s, 3H, OCH3), 3.72 (s, 3H, 
OCH3), 3.48 (dd, J = 12.0 Hz, 3.2 Hz, H5'), 3.34 (dd, J = 12.0 Hz, 3.2 Hz, H5'), 2.75 (m, 1H, H2'); 
13
C NMR (101 MHz, DMSO-d6)   165.2, 163.1, 158.9, 152.4, 151.8, 151.2, 150.3, 144.1, 144.2, 
139.9, 135.1, 133.5, 133.0, 130.1, 130.2, 128.9, 128.3, 128.2, 128.1, 128.0, 127.3, 123.1, 113.4 (Ar, 
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C2,4,5,6,8(A), C2,4,6(U)), 103.2 (C5), 87.4 (CAr3), 86.3 (C4'), 86.2 (C1'), 72.2 (C3'), 64.0 (C5'), 
55.4 (OCH3), 52.0 (C2'), 39.9 (2'-CH2); ESI HRMS: m/z 804.2775 ([M - Na]
+
, C40H38N6O7Na
+
 
calcd. 804.2752). 
 
Synthesis of 5'-O-(4,4'-dimethoxytrityl)-3'-O-(P-β-cyanoethoxy-N,N-diisopropylaminophos-
phinyl)-2'-C-(N6-benzoyladenine-9-yl)methyl-2'-deoxyuridine (7). The nucleoside 6 (78 mg, 
0.10 mmol) was co-evaporated with anhydrous 1,2-dichlorethane (2  2 mL) and dissolved in 
anhydrous CH2Cl2 (2.0 mL). Diisopropylammonium tetrazolide (40 mg, 0.2 mmol) and 2-
cyanoethyl-N,N,N',N'-tetraisopropylphosphoramidite (63 µL, 0.2 mmol) were added, and the 
mixture was stirred at room temperature for 14 h. Absolute ethanol (2-3 drops) was added, and the 
reaction mixture was concentrated under reduced pressure. The residue was purified by flash 
column chromatography (0-4% MeOH in CH2Cl2) to give the product 7 (64 mg, 65%) as a white 
solid. Rf 0.5 (4% MeOH in CH2Cl2). 
31
P NMR (162 MHz, CDCl3) δ 151.1, 149.7. ESI HRMS: m/z 
1004.3825 ([M - Na]
+
, C52H56N9O9PNa
+
 calcd. 1004.3831). 
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Experimental data for oligonucleotide synthesis, hybridisation experiments and CD 
spectroscopy 
 
Oligonucleotide synthesis. Oligonucleotide synthesis was carried out on an automated DNA 
synthesizer following the phosphoramidite approach. Synthesis of oligonucleotides ON1-ON5  (See 
Table S1) were performed on a 0.2 µmol scale (CPG support) by using the modified nucleoside 
phosphoramidite 7 to introduce monomer UA as well as the corresponding commercial 2-cyanoethyl 
phosphoramidites of the natural 2′-deoxynucleosides. The synthesis followed the regular protocol 
for the DNA synthesizer. For the modified phosphoramidite a prolonged coupling time of 15 min. 
was used. 1H-Tetrazole was used as activator. In general coupling yields for the modified 
phosphoramidite was >50%.  For commercial 2-cyanoethyl phosphoramidites of the natural 2'-
deoxynucleosides, coupling yield of >95% was obtained. The 5′-O-DMT-ON oligonucleotides were 
removed from the solid support by treatment with concentrated aqueous ammonia at 55C for 12h. 
The oligonucleotides were purified by reversed-phase HPLC C18 10µm; 7.8150 mm column + 
precolumn: C18 10µm, 7.810 mm. Buffer A: 0.05 M Triethyl Ammonium Acetate, pH 7.4. Buffer 
B: 75 % MeCN/H2O (3:1, v/v). Program used: 2 min 100% A, 100-30% A over 38 min, 10 min 
100% B, 10 min 100% A. All oligonucleotides were detritylated by treatment with 80% aqueous 
acetic acid for 20 min, neutralized by addition of sodium acetate (3 M, 15 L), then added sodium 
perchlorate (5 M, 15 L) followed by acetone (1 mL). The pure oligonucleotides were precipitated 
over night at 20C. The mixture was then placed in a centrifuge and subjected to 12000 rpm, 10 
min at 4C. The supernatant was removed and the pellet washed with cold acetone (2 × 1 mL). The 
pellet was then dried for 30 min under reduced pressure, dissolved in pure water (1mL) and the 
concentration measured as OD 260 nm. The purity and constitution of the ON’s were confirmed by 
IC analysis and MALDI-TOF MS [M - H]
+
, respectively (Table S1). 
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Thermal denaturation experiments. Samples were dissolved in a medium salt buffer containing 2.5 
mM Na2HPO4, 5 mM NaH2PO4, 100 mM NaCl, and 0.1 mM EDTA at pH = 7.0 with 1.0 μM 
concentrations of the two complementary oligonucleotide sequences. The increase in UV 
absorbance at 260 nm as a function of time was recorded while the temperature was increased 
linearly from 10 to 75C at a rate of 1.0C/min by means of a Peltier temperature programmer. The 
melting curves were found to be reversible. All determinations are averages of at least duplicates 
within  0.5C. 
 
CD spectroscopy. Samples were dissolved in a medium salt buffer containing 2.5 mM Na2HPO4, 5 
mM NaH2PO4, 100 mM NaCl, and 0.1 mM EDTA at pH = 7.0 with 1.0 μM concentrations of the 
two complementary oligonucleotide sequences, heated to 80°C and cooled to 10°C. Quartz optical 
cells with a path length of 5.0 mm were used. CD-spectra (200-350 nm) were recorded on a JASCO 
J-815 CD-spectrometer as an average of 5 scans using a split of 2.0 nm, and a scan speed of 50 
nm/min.  
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Table S1. MALDI-TOF MS data of synthesized ON’s 
ON Sequence MW (calcd./exp.) 
ON1 5′-d(CGC ATA XTC GC)-3′ 3425.0/3425.0 
ON2 5′-d(CGC AXA TTC GC)-3′ 3425.0/3424.8 
ON3 5′-d(GCG AAT AXG CG)-3′ 3514.0/3515.4 
ON4 5′-d(GCG AAX ATG CG)-3′ 3514.0/3514.7 
ON5 5′-d(GCT CAC XCT CCC A)-3′ 3963.4/3963.0 
 
 
Table S2. Tm data for modified duplexes. 
Entry Duplex 
Zipper Tm /°C
 a
 
(ΔTm /°C)
 b
 
1. 
5'-d(CGC AUA ATT CGC) 
3'-d(GCG TAT UAA GCG) 
 46.0 
2. 
5'-d(CGC AUAA TTC GC) 
3'-d(GCG TAT UAA GCG) 
 43.5 
3. 
5'-d(CGC ATA TTC GC) 
3'-d(GCG TAT AAG CG) 
 
45.0 
4. 
5'-d(CGC ATA UATC GC) 
3'-d(GCG TAT AAG CG) 
 34.0 
(–11.0) 
5. 
5'-d(CGC AUAA TTC GC) 
3'-d(GCG TAT AAG CG) 
 40.0 
(–5.0) 
6. 
5'-d(CGC ATA TTC GC) 
3'-d(GCG UAAT AAG CG) 
 37.0 
(–8.0) 
7. 
5'-d(CGC ATA TTC GC) 
3'-d(GCG TAUA AAG CG) 
 39.5 
(–5.5) 
8. 
5'-d(CGC AUAA TTC GC) 
3'-d(GCG UAAT AAG CG) 
(–1) 
28.0 
(–17.0) 
9. 
5'-d(CGC ATA UATC GC) 
3'-d(GCG TAUA AAG CG) 
(–1) 
28.5 
(–16.5) 
10. 
5'-d(CGC ATA UATC GC) 
3'-d(GCG UAAT AAG CG) 
(–3) 
22.0 
(–23.0) 
 
a
 Melting temperatures obtained from the maxima of the first derivatives of the melting curves (A260 vs. 
temperature) recorded in a
 
buffer containing 2.5 mM Na2HPO4, 5.0 mM NaH2PO4, 100 mM NaCl, 0.1 mM 
EDTA, pH 7.0 using 1.0 M concentrations of each strand. bDifferences in melting temperatures as 
compared to the unmodified duplex (entry 3). 
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Melting curves: 
 
Figure S1. Melting curves for the duplexes given in Table 1. 
 
 
  
Figure S2. Melting curves for the duplexes given in Table 2. 
 
 
Figure S3. Melting curves for the duplexes given in Table S2. 
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CD curves: 
 
Figure S4. CD curves for the duplexes given in Table 1. 
 
 
Figure S5. CD curves for the duplexes given in Table 2. 
 
 
Figure S6. CD curves for the duplexes given in Table S2. 
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MOLECULAR MODELLING 
 
Setting up the UA library file. The modified nucleoside was built in xleap with the two nucleobases 
stacking and geometry optimised at the HF/6-31G* level using Gaussian03.
S2
 The backbone 
conformation of the optimised nucleoside remained in a duplex-like geometry through the geometry 
optimisation. Atomic charges were calculated using the RESP methodology
S3
 keeping the native 
charges from the force field of Cornell et al. for backbone and sugar atoms except for C1′, C2′, H1′ 
and H2′.S4,S5 In this manner we were consistent with the charge derivation for the native atomic 
charges. Atom types and atomic charges for UA are shown in Table S3. 
 
Setting up the deoxy-U library file. The methyl group of thymidine was changed to a hydrogen 
(atom type HA) in xleap and atomic charges were calculated in a manner consistent with the charge 
derivation in AMBER as described by Kollman and co-workers.
S5
  
 
Building UA/UT-modified duplexes. All starting coordinates were generated using idealised B-DNA 
geometries. For duplexes containing UA or UT residues, helices with two thymidines at the UA/UT 
site(s) were built initially and the resulting pdb file edited by deleting the second thymidine(s) and 
the methyl group of the first thymidine(s) and changing the name of the UA/UT unit appropriately to 
be recognised by the LEaP module of AMBER. For duplexes containing deoxy-U residues, helices 
with a thymidine at the dU were built, the methyl group deleted and the residue name changed 
appropriately. In LEaP, net-neutralizing Na
+
 ions were added and the whole system was surrounded 
by a truncated octahedron of TIP3P waters with a minimum distance of 10.0 Å from the helix to the 
edges of the box. 
 
MD simulations. All MD simulations were carried out with AMBER9 program suite
S6,S7
using the 
ff99
S8
 and ff99-bsc0
S9
 parameters for nucleic acids and ions. The TIP3P water model was used.
S10
 
For UA/UT-modified systems, an initial energy minimisation was performed with only the UA/UT 
residue and the 3′-following nucleotide free to move. Harmonic positional restraints with a force 
constant of 500 kcal mol
−1
 Å
–2
 were applied to the remainder of the system. This energy 
minimisation relieved the strain on the modified backbone. Afterwards, harmonic positional 
restraints with a force constant of 500 kcal mol
−1
 Å
–2
 were applied to the entire duplex. The system 
was minimised for 500 steps of steepest descent and 500 steps of conjugate gradient minimisation. 
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Finally, a further 1000 steps of steepest descent and 1500 steps of conjugate gradient minimisation 
was carried out with the entire system free to move. 
 In the MD equilibration, the SHAKE algorithm was applied with a 1 fs time step. The non-
bond cutoff was 9 Å and the particle mesh Ewald method with default parameters was used to 
calculate long-range electrostatic interactions. The temperature of the system was raised from 0 to 
300 K over 20 ps at constant volume using the Berendsen thermostat with a 0.2 ps coupling 
parameter and applying harmonic positional restraints with a force constant of 10 kcal mol
−1
 Å
–2
 to 
the DNA molecules. Centre of mass movement was removed every 1000th step. Subsequently, 10 
ps MD was carried out at 300 K at constant volume and temperature with parameters as in the first 
round of equilibration. The final step of equilibration consisted of 200 ps unrestrained NPT MD at 
300 K with a time step of 2 ps. The reference pressure was 1 atm and the barostat coupling 
parameter 2.0 ps and the thermostat coupling parameter 1.0 ps. Production runs were carried out for 
50 ns with parameters as for the last step of the equilibration except for the pressure and temperature 
coupling parameters which both were 5.0 ps. For each possible base pairing scheme for the 
additional A:T base pair, three production runs were initiated with different random initial atom 
velocities. 
 
Free energy calculations. To evaluate the difference in free energy between the possible base 
pairing schemes in the 5′-UAA:3′-AUT motif, snapshots where the relevant base pairing was 
maintained were extracted from the last 40 ns of each trajectories. Snapshots were extracted every 
20th ps resulting in 6000 snapshots for Watson-Crick base pairing, 5589 snapshots for reverse 
Watson-Crick base pairing and 1002 snapshots for reverse Hoogsteen base pairing.  
 In the MM-PBSA approach, the relevant energy quantities were averaged over the snapshots 
stripped for explicit water molecules and ions. To calculate the gas phase energy and the solvation 
free energy, the perl script mm_pbsa.pl in the AMBER9 suite was used. The gas phase energy was 
found from the force field energies using a dielectric constant of 1.0. The polar contribution to the 
solvation free energy was found by solving the linear Poisson Boltzmann (PB) equation with 1000 
steps of iteration. The ionic strength was set to 100 mM, the internal dielectric constant to 1.0 and 
the external dielectric constant to 80.0. The nonpolar solvation free energy was calculated using the 
solvent-accessible-surface-area (SASA), a surface tension of 0.0072 kcal Å
−2
 mol
−1
 and no 
correcting offset. The entropic contribution was estimated using the nmode program in AMBER9 
assuming the rigid rotor and harmonic approximation to the normal modes at 300 K. For the 
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calculation of the entropy, the stripped snapshots were prepared in the same way as described 
above. These structures were minimized for 50,000 steps or until the root-mean-square of the 
elements of the gradient vector reached below 10
−4
 kcal mol
−1
 Å
−1
 using a distance-dependent 
dielectric constant of 4r and a non-bonded cut-off of 99 Å and then minimised further with the 
Newton-Raphson method up to 100 steps until the root-mean-square of the elements of the gradient 
vector reached below 10
−5
 kcal mol
–1
 Å
–1
. 
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Table S3. Atom types and partial atomic charges for the UA nucleotide. C6′, H6′a and H6′b are the 
atoms in the methylene linker and atoms in the additional adenine base are labelled with an “(A)”. 
 
Atom 
Name 
Atom 
type 
Partial 
charge 
 
Atom 
name 
Atom 
type 
Partial 
charge 
 
Atom 
name 
Atom 
type 
Partial 
charge 
P P 1.165900  H3′ H1 0.098500  O2 O −0.568385 
O1P O2 −0.776100  O3′ OS −0.523200  N9(A) N* −0.074524 
O2P O2 −0.776100  C6′ CT −0.054842  C8(A) CK 0.093916 
O5′ OS −0.495400  H6′a H1 0.106284  H8(A) H5 0.160471 
C5′ CI −0.006900  H6′b H1 0.106284  N7(A) NB −0.536798 
H5′a H1 0.075400  N1 N* 0.131023  C5(A) CB 0.014810 
H5′b H1 0.075400  C6 CM −0.114132  C6(A) CA 0.675204 
C4′ CT 0.162900  H6 H4 0.258196  C4(A) CB 0.423008 
H4′ H1 0.117600  C5 CM −0.423694  N3(A) NC −0.659643 
O4′ OS −0.369100  H5 HA 0.192830  N1(A) NC −0.730828 
C1′ CT −0.159785  C4 C 0.691706  C2(A) CQ 0.516247 
H1′ H2 0.239636  O4 O −0.575474  N6(A) N2 −0.895838 
C2′ CT 0.007816  N3 NA −0.465520  H61(A) H 0.404126 
H2′ HC 0.060566  H3 H 0.328269  H62(A) H 0.404126 
C3′ CT 0.071300  C2 C 0.561750  H2(A) H5 0.062995 
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